nodes	percent_of_prediction	percent_of_DWPC	metapath
Neomycin—Framycetin—CXCR4—breast cancer	0.0441	1	CrCbGaD
Neomycin—Ototoxicity—Vinorelbine—breast cancer	0.0435	0.0455	CcSEcCtD
Neomycin—Ototoxicity—Thiotepa—breast cancer	0.0416	0.0435	CcSEcCtD
Neomycin—Ototoxicity—Paclitaxel—breast cancer	0.0293	0.0306	CcSEcCtD
Neomycin—Nerve injury—Paclitaxel—breast cancer	0.0269	0.0281	CcSEcCtD
Neomycin—Glaucoma—Toremifene—breast cancer	0.0253	0.0265	CcSEcCtD
Neomycin—Ototoxicity—Docetaxel—breast cancer	0.0248	0.026	CcSEcCtD
Neomycin—Malabsorption—Methotrexate—breast cancer	0.0247	0.0259	CcSEcCtD
Neomycin—Impaired healing—Melphalan—breast cancer	0.0231	0.0242	CcSEcCtD
Neomycin—Viral infection—Exemestane—breast cancer	0.0186	0.0194	CcSEcCtD
Neomycin—Viral infection—Letrozole—breast cancer	0.0165	0.0173	CcSEcCtD
Neomycin—Nephropathy toxic—Vinorelbine—breast cancer	0.0152	0.0159	CcSEcCtD
Neomycin—Nephropathy toxic—Mitoxantrone—breast cancer	0.0125	0.0131	CcSEcCtD
Neomycin—Swelling—Anastrozole—breast cancer	0.0123	0.0128	CcSEcCtD
Neomycin—Nephropathy toxic—Gemcitabine—breast cancer	0.0122	0.0128	CcSEcCtD
Neomycin—Secondary infection—Epirubicin—breast cancer	0.0114	0.012	CcSEcCtD
Neomycin—Secondary infection—Doxorubicin—breast cancer	0.0106	0.0111	CcSEcCtD
Neomycin—Anaphylactic shock—Fluoxymesterone—breast cancer	0.0106	0.0111	CcSEcCtD
Neomycin—Nephropathy toxic—Paclitaxel—breast cancer	0.0102	0.0107	CcSEcCtD
Neomycin—Sensitisation—Epirubicin—breast cancer	0.0094	0.00984	CcSEcCtD
Neomycin—Sensitisation—Doxorubicin—breast cancer	0.0087	0.0091	CcSEcCtD
Neomycin—Swelling—Tamoxifen—breast cancer	0.0084	0.00879	CcSEcCtD
Neomycin—Impaired healing—Methotrexate—breast cancer	0.0083	0.00868	CcSEcCtD
Neomycin—Swelling—Goserelin—breast cancer	0.00802	0.00839	CcSEcCtD
Neomycin—Viral infection—Mitoxantrone—breast cancer	0.00797	0.00834	CcSEcCtD
Neomycin—Infection—Carboplatin—breast cancer	0.0079	0.00827	CcSEcCtD
Neomycin—Hypersensitivity—Fluoxymesterone—breast cancer	0.00778	0.00814	CcSEcCtD
Neomycin—Anaphylactic shock—Lapatinib—breast cancer	0.0075	0.00785	CcSEcCtD
Neomycin—Infection—Lapatinib—breast cancer	0.00745	0.00779	CcSEcCtD
Neomycin—Infection—Fulvestrant—breast cancer	0.00685	0.00717	CcSEcCtD
Neomycin—Erythema—Anastrozole—breast cancer	0.00652	0.00682	CcSEcCtD
Neomycin—Viral infection—Paclitaxel—breast cancer	0.0065	0.0068	CcSEcCtD
Neomycin—Nausea—Fluoxymesterone—breast cancer	0.00627	0.00656	CcSEcCtD
Neomycin—Infection—Exemestane—breast cancer	0.00595	0.00623	CcSEcCtD
Neomycin—Swelling—Mitoxantrone—breast cancer	0.00593	0.0062	CcSEcCtD
Neomycin—Swelling—Fluorouracil—breast cancer	0.00568	0.00594	CcSEcCtD
Neomycin—Infection—Ixabepilone—breast cancer	0.00562	0.00587	CcSEcCtD
Neomycin—Hypersensitivity—Lapatinib—breast cancer	0.00553	0.00578	CcSEcCtD
Neomycin—Anaphylactic shock—Anastrozole—breast cancer	0.00532	0.00557	CcSEcCtD
Neomycin—Anaphylactic shock—Letrozole—breast cancer	0.00532	0.00557	CcSEcCtD
Neomycin—Pruritus—Lapatinib—breast cancer	0.00531	0.00555	CcSEcCtD
Neomycin—Infection—Anastrozole—breast cancer	0.00529	0.00553	CcSEcCtD
Neomycin—Infection—Letrozole—breast cancer	0.00529	0.00553	CcSEcCtD
Neomycin—Diarrhoea—Lapatinib—breast cancer	0.00513	0.00537	CcSEcCtD
Neomycin—Hypersensitivity—Fulvestrant—breast cancer	0.00508	0.00532	CcSEcCtD
Neomycin—Anaphylactic shock—Idarubicin—breast cancer	0.00505	0.00528	CcSEcCtD
Neomycin—Infection—Raloxifene—breast cancer	0.00502	0.00525	CcSEcCtD
Neomycin—Infection—Idarubicin—breast cancer	0.00502	0.00525	CcSEcCtD
Neomycin—Pruritus—Fulvestrant—breast cancer	0.00488	0.0051	CcSEcCtD
Neomycin—Swelling—Paclitaxel—breast cancer	0.00483	0.00506	CcSEcCtD
Neomycin—Pruritus—Toremifene—breast cancer	0.00482	0.00504	CcSEcCtD
Neomycin—Vomiting—Lapatinib—breast cancer	0.00477	0.00499	CcSEcCtD
Neomycin—Diarrhoea—Fulvestrant—breast cancer	0.00472	0.00494	CcSEcCtD
Neomycin—Erythema—Tamoxifen—breast cancer	0.00446	0.00467	CcSEcCtD
Neomycin—Nausea—Lapatinib—breast cancer	0.00445	0.00466	CcSEcCtD
Neomycin—Hypersensitivity—Exemestane—breast cancer	0.00441	0.00462	CcSEcCtD
Neomycin—Vomiting—Fulvestrant—breast cancer	0.00439	0.00459	CcSEcCtD
Neomycin—Vomiting—Toremifene—breast cancer	0.00433	0.00453	CcSEcCtD
Neomycin—Erythema—Goserelin—breast cancer	0.00426	0.00446	CcSEcCtD
Neomycin—Pruritus—Exemestane—breast cancer	0.00424	0.00443	CcSEcCtD
Neomycin—Hypersensitivity—Ixabepilone—breast cancer	0.00416	0.00436	CcSEcCtD
Neomycin—Diarrhoea—Exemestane—breast cancer	0.0041	0.00429	CcSEcCtD
Neomycin—Swelling—Docetaxel—breast cancer	0.0041	0.00429	CcSEcCtD
Neomycin—Nausea—Fulvestrant—breast cancer	0.0041	0.00429	CcSEcCtD
Neomycin—Infection—Chlorambucil—breast cancer	0.00406	0.00425	CcSEcCtD
Neomycin—Nausea—Toremifene—breast cancer	0.00404	0.00423	CcSEcCtD
Neomycin—Pruritus—Ixabepilone—breast cancer	0.004	0.00418	CcSEcCtD
Neomycin—Swelling—Capecitabine—breast cancer	0.00397	0.00415	CcSEcCtD
Neomycin—Hypersensitivity—Anastrozole—breast cancer	0.00392	0.0041	CcSEcCtD
Neomycin—Diarrhoea—Ixabepilone—breast cancer	0.00387	0.00405	CcSEcCtD
Neomycin—Erythema—Vinorelbine—breast cancer	0.00382	0.00399	CcSEcCtD
Neomycin—Vomiting—Exemestane—breast cancer	0.00381	0.00398	CcSEcCtD
Neomycin—Pruritus—Letrozole—breast cancer	0.00377	0.00394	CcSEcCtD
Neomycin—Pruritus—Anastrozole—breast cancer	0.00377	0.00394	CcSEcCtD
Neomycin—Hypersensitivity—Idarubicin—breast cancer	0.00372	0.00389	CcSEcCtD
Neomycin—Viral infection—Epirubicin—breast cancer	0.00372	0.00389	CcSEcCtD
Neomycin—Erythema—Thiotepa—breast cancer	0.00365	0.00381	CcSEcCtD
Neomycin—Diarrhoea—Anastrozole—breast cancer	0.00364	0.00381	CcSEcCtD
Neomycin—Diarrhoea—Letrozole—breast cancer	0.00364	0.00381	CcSEcCtD
Neomycin—Infection—Tamoxifen—breast cancer	0.00362	0.00379	CcSEcCtD
Neomycin—Vomiting—Ixabepilone—breast cancer	0.00359	0.00376	CcSEcCtD
Neomycin—Anaphylactic shock—Melphalan—breast cancer	0.00357	0.00373	CcSEcCtD
Neomycin—Nausea—Exemestane—breast cancer	0.00356	0.00372	CcSEcCtD
Neomycin—Infection—Melphalan—breast cancer	0.00354	0.00371	CcSEcCtD
Neomycin—Anaphylactic shock—Goserelin—breast cancer	0.00348	0.00364	CcSEcCtD
Neomycin—Diarrhoea—Idarubicin—breast cancer	0.00346	0.00362	CcSEcCtD
Neomycin—Diarrhoea—Raloxifene—breast cancer	0.00346	0.00362	CcSEcCtD
Neomycin—Infection—Goserelin—breast cancer	0.00346	0.00362	CcSEcCtD
Neomycin—Viral infection—Doxorubicin—breast cancer	0.00344	0.0036	CcSEcCtD
Neomycin—Vomiting—Letrozole—breast cancer	0.00338	0.00354	CcSEcCtD
Neomycin—Vomiting—Anastrozole—breast cancer	0.00338	0.00354	CcSEcCtD
Neomycin—Nausea—Ixabepilone—breast cancer	0.00336	0.00351	CcSEcCtD
Neomycin—Vomiting—Raloxifene—breast cancer	0.00321	0.00336	CcSEcCtD
Neomycin—Vomiting—Idarubicin—breast cancer	0.00321	0.00336	CcSEcCtD
Neomycin—Nausea—Letrozole—breast cancer	0.00316	0.00331	CcSEcCtD
Neomycin—Nausea—Anastrozole—breast cancer	0.00316	0.00331	CcSEcCtD
Neomycin—Erythema—Mitoxantrone—breast cancer	0.00315	0.00329	CcSEcCtD
Neomycin—Anaphylactic shock—Vinorelbine—breast cancer	0.00312	0.00326	CcSEcCtD
Neomycin—Infection—Vinorelbine—breast cancer	0.0031	0.00324	CcSEcCtD
Neomycin—Erythema—Gemcitabine—breast cancer	0.00307	0.00321	CcSEcCtD
Neomycin—Erythema—Fluorouracil—breast cancer	0.00302	0.00315	CcSEcCtD
Neomycin—Hypersensitivity—Chlorambucil—breast cancer	0.00301	0.00315	CcSEcCtD
Neomycin—Nausea—Raloxifene—breast cancer	0.003	0.00314	CcSEcCtD
Neomycin—Nausea—Idarubicin—breast cancer	0.003	0.00314	CcSEcCtD
Neomycin—Infection—Thiotepa—breast cancer	0.00296	0.00309	CcSEcCtD
Neomycin—Pruritus—Chlorambucil—breast cancer	0.00289	0.00303	CcSEcCtD
Neomycin—Diarrhoea—Chlorambucil—breast cancer	0.0028	0.00293	CcSEcCtD
Neomycin—Hypersensitivity—Vinblastine—breast cancer	0.00276	0.00289	CcSEcCtD
Neomycin—Hypersensitivity—Tamoxifen—breast cancer	0.00268	0.00281	CcSEcCtD
Neomycin—Hypersensitivity—Melphalan—breast cancer	0.00263	0.00275	CcSEcCtD
Neomycin—Vomiting—Chlorambucil—breast cancer	0.0026	0.00272	CcSEcCtD
Neomycin—Pruritus—Tamoxifen—breast cancer	0.00258	0.0027	CcSEcCtD
Neomycin—Anaphylactic shock—Mitoxantrone—breast cancer	0.00257	0.00269	CcSEcCtD
Neomycin—Anaphylactic shock—Irinotecan—breast cancer	0.00257	0.00269	CcSEcCtD
Neomycin—Erythema—Paclitaxel—breast cancer	0.00257	0.00269	CcSEcCtD
Neomycin—Diarrhoea—Vinblastine—breast cancer	0.00257	0.00268	CcSEcCtD
Neomycin—Hypersensitivity—Goserelin—breast cancer	0.00256	0.00268	CcSEcCtD
Neomycin—Infection—Mitoxantrone—breast cancer	0.00255	0.00267	CcSEcCtD
Neomycin—Infection—Irinotecan—breast cancer	0.00255	0.00267	CcSEcCtD
Neomycin—Pruritus—Melphalan—breast cancer	0.00252	0.00264	CcSEcCtD
Neomycin—Anaphylactic shock—Gemcitabine—breast cancer	0.0025	0.00262	CcSEcCtD
Neomycin—Diarrhoea—Tamoxifen—breast cancer	0.00249	0.00261	CcSEcCtD
Neomycin—Infection—Gemcitabine—breast cancer	0.00249	0.0026	CcSEcCtD
Neomycin—Pruritus—Goserelin—breast cancer	0.00246	0.00257	CcSEcCtD
Neomycin—Anaphylactic shock—Fluorouracil—breast cancer	0.00246	0.00257	CcSEcCtD
Neomycin—Infection—Fluorouracil—breast cancer	0.00245	0.00256	CcSEcCtD
Neomycin—Diarrhoea—Melphalan—breast cancer	0.00244	0.00255	CcSEcCtD
Neomycin—Nausea—Chlorambucil—breast cancer	0.00243	0.00254	CcSEcCtD
Neomycin—Vomiting—Vinblastine—breast cancer	0.00238	0.00249	CcSEcCtD
Neomycin—Diarrhoea—Goserelin—breast cancer	0.00238	0.00249	CcSEcCtD
Neomycin—Vomiting—Tamoxifen—breast cancer	0.00232	0.00242	CcSEcCtD
Neomycin—Hypersensitivity—Vinorelbine—breast cancer	0.0023	0.0024	CcSEcCtD
Neomycin—Vomiting—Melphalan—breast cancer	0.00227	0.00237	CcSEcCtD
Neomycin—Nausea—Vinblastine—breast cancer	0.00223	0.00233	CcSEcCtD
Neomycin—Vomiting—Goserelin—breast cancer	0.00221	0.00231	CcSEcCtD
Neomycin—Pruritus—Vinorelbine—breast cancer	0.0022	0.00231	CcSEcCtD
Neomycin—Hypersensitivity—Thiotepa—breast cancer	0.00219	0.00229	CcSEcCtD
Neomycin—Erythema—Docetaxel—breast cancer	0.00218	0.00228	CcSEcCtD
Neomycin—Nausea—Tamoxifen—breast cancer	0.00216	0.00226	CcSEcCtD
Neomycin—Diarrhoea—Vinorelbine—breast cancer	0.00213	0.00223	CcSEcCtD
Neomycin—Nausea—Melphalan—breast cancer	0.00212	0.00222	CcSEcCtD
Neomycin—Erythema—Capecitabine—breast cancer	0.00211	0.0022	CcSEcCtD
Neomycin—Pruritus—Thiotepa—breast cancer	0.00211	0.0022	CcSEcCtD
Neomycin—Anaphylactic shock—Paclitaxel—breast cancer	0.0021	0.00219	CcSEcCtD
Neomycin—Infection—Paclitaxel—breast cancer	0.00208	0.00218	CcSEcCtD
Neomycin—Nausea—Goserelin—breast cancer	0.00207	0.00216	CcSEcCtD
Neomycin—Diarrhoea—Thiotepa—breast cancer	0.00204	0.00213	CcSEcCtD
Neomycin—Vomiting—Vinorelbine—breast cancer	0.00198	0.00207	CcSEcCtD
Neomycin—Hypersensitivity—Mitoxantrone—breast cancer	0.00189	0.00198	CcSEcCtD
Neomycin—Hypersensitivity—Irinotecan—breast cancer	0.00189	0.00198	CcSEcCtD
Neomycin—Vomiting—Thiotepa—breast cancer	0.00189	0.00198	CcSEcCtD
Neomycin—Nausea—Vinorelbine—breast cancer	0.00185	0.00194	CcSEcCtD
Neomycin—Hypersensitivity—Fluorouracil—breast cancer	0.00181	0.0019	CcSEcCtD
Neomycin—Anaphylactic shock—Docetaxel—breast cancer	0.00178	0.00186	CcSEcCtD
Neomycin—Pruritus—Gemcitabine—breast cancer	0.00177	0.00185	CcSEcCtD
Neomycin—Nausea—Thiotepa—breast cancer	0.00177	0.00185	CcSEcCtD
Neomycin—Infection—Docetaxel—breast cancer	0.00176	0.00185	CcSEcCtD
Neomycin—Diarrhoea—Mitoxantrone—breast cancer	0.00176	0.00184	CcSEcCtD
Neomycin—Diarrhoea—Irinotecan—breast cancer	0.00176	0.00184	CcSEcCtD
Neomycin—Pruritus—Fluorouracil—breast cancer	0.00174	0.00182	CcSEcCtD
Neomycin—Diarrhoea—Gemcitabine—breast cancer	0.00171	0.00179	CcSEcCtD
Neomycin—Infection—Capecitabine—breast cancer	0.00171	0.00179	CcSEcCtD
Neomycin—Diarrhoea—Fluorouracil—breast cancer	0.00168	0.00176	CcSEcCtD
Neomycin—Vomiting—Irinotecan—breast cancer	0.00163	0.00171	CcSEcCtD
Neomycin—Vomiting—Mitoxantrone—breast cancer	0.00163	0.00171	CcSEcCtD
Neomycin—Vomiting—Gemcitabine—breast cancer	0.00159	0.00166	CcSEcCtD
Neomycin—Erythema—Methotrexate—breast cancer	0.00157	0.00164	CcSEcCtD
Neomycin—Vomiting—Fluorouracil—breast cancer	0.00156	0.00164	CcSEcCtD
Neomycin—Hypersensitivity—Paclitaxel—breast cancer	0.00154	0.00162	CcSEcCtD
Neomycin—Nausea—Mitoxantrone—breast cancer	0.00153	0.0016	CcSEcCtD
Neomycin—Nausea—Irinotecan—breast cancer	0.00153	0.0016	CcSEcCtD
Neomycin—Nausea—Gemcitabine—breast cancer	0.00149	0.00156	CcSEcCtD
Neomycin—Pruritus—Paclitaxel—breast cancer	0.00148	0.00155	CcSEcCtD
Neomycin—Erythema—Epirubicin—breast cancer	0.00147	0.00154	CcSEcCtD
Neomycin—Nausea—Fluorouracil—breast cancer	0.00146	0.00153	CcSEcCtD
Neomycin—Diarrhoea—Paclitaxel—breast cancer	0.00143	0.0015	CcSEcCtD
Neomycin—Erythema—Doxorubicin—breast cancer	0.00136	0.00142	CcSEcCtD
Neomycin—Vomiting—Paclitaxel—breast cancer	0.00133	0.00139	CcSEcCtD
Neomycin—Hypersensitivity—Docetaxel—breast cancer	0.00131	0.00137	CcSEcCtD
Neomycin—Anaphylactic shock—Methotrexate—breast cancer	0.00128	0.00134	CcSEcCtD
Neomycin—Infection—Methotrexate—breast cancer	0.00127	0.00133	CcSEcCtD
Neomycin—Hypersensitivity—Capecitabine—breast cancer	0.00127	0.00133	CcSEcCtD
Neomycin—Pruritus—Docetaxel—breast cancer	0.00126	0.00131	CcSEcCtD
Neomycin—Nausea—Paclitaxel—breast cancer	0.00124	0.0013	CcSEcCtD
Neomycin—Pruritus—Capecitabine—breast cancer	0.00122	0.00127	CcSEcCtD
Neomycin—Diarrhoea—Docetaxel—breast cancer	0.00122	0.00127	CcSEcCtD
Neomycin—Anaphylactic shock—Epirubicin—breast cancer	0.0012	0.00125	CcSEcCtD
Neomycin—Infection—Epirubicin—breast cancer	0.00119	0.00125	CcSEcCtD
Neomycin—Diarrhoea—Capecitabine—breast cancer	0.00118	0.00123	CcSEcCtD
Neomycin—Vomiting—Docetaxel—breast cancer	0.00113	0.00118	CcSEcCtD
Neomycin—Anaphylactic shock—Doxorubicin—breast cancer	0.00111	0.00116	CcSEcCtD
Neomycin—Infection—Doxorubicin—breast cancer	0.0011	0.00115	CcSEcCtD
Neomycin—Vomiting—Capecitabine—breast cancer	0.00109	0.00114	CcSEcCtD
Neomycin—Nausea—Docetaxel—breast cancer	0.00106	0.0011	CcSEcCtD
Neomycin—Nausea—Capecitabine—breast cancer	0.00102	0.00107	CcSEcCtD
Neomycin—Hypersensitivity—Methotrexate—breast cancer	0.000943	0.000987	CcSEcCtD
Neomycin—Pruritus—Methotrexate—breast cancer	0.000906	0.000948	CcSEcCtD
Neomycin—Hypersensitivity—Epirubicin—breast cancer	0.000883	0.000923	CcSEcCtD
Neomycin—Diarrhoea—Methotrexate—breast cancer	0.000876	0.000916	CcSEcCtD
Neomycin—Pruritus—Epirubicin—breast cancer	0.000848	0.000887	CcSEcCtD
Neomycin—Diarrhoea—Epirubicin—breast cancer	0.00082	0.000858	CcSEcCtD
Neomycin—Hypersensitivity—Doxorubicin—breast cancer	0.000817	0.000854	CcSEcCtD
Neomycin—Vomiting—Methotrexate—breast cancer	0.000814	0.000852	CcSEcCtD
Neomycin—Pruritus—Doxorubicin—breast cancer	0.000784	0.000821	CcSEcCtD
Neomycin—Vomiting—Epirubicin—breast cancer	0.000762	0.000797	CcSEcCtD
Neomycin—Nausea—Methotrexate—breast cancer	0.00076	0.000796	CcSEcCtD
Neomycin—Diarrhoea—Doxorubicin—breast cancer	0.000759	0.000794	CcSEcCtD
Neomycin—Nausea—Epirubicin—breast cancer	0.000712	0.000745	CcSEcCtD
Neomycin—Vomiting—Doxorubicin—breast cancer	0.000705	0.000737	CcSEcCtD
Neomycin—Nausea—Doxorubicin—breast cancer	0.000659	0.000689	CcSEcCtD
